FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy - Wikidata - wikimedia - TriplyDB

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

http://www.wikidata.org/entity/Q35917428

about

Fibroblast growth factor 23 The use of fibroblast growth factor 23 testing in patients with kidney disease.Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline.Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients.Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion.Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness.Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients.Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.What's new in FGF23 research?Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study Disordered FGF23 and mineral metabolism in children with CKD Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review Treatment of IgA nephropathy and Henoch-Schönlein nephritis.Biomarkers in IgA nephropathy: relationship to pathogenetic hits.Proteomic biomarkers in kidney disease: issues in development and implementation.Phosphate and FGF-23 homeostasis after kidney transplantation.Dietary Phosphorus Intake and the Kidney.IgA nephropathy: association of C4d with clinical and histopathological findings and possible role of IgM.Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.

P2860

Q26829294-CC074576-AF0C-47BB-83B0-2963D4CA5C17 Q33835743-70734805-B411-41B1-BE40-D91B81B0AE66 Q33873450-E75E684D-E4E7-4E33-AF9D-25BDB62E00BB Q34204949-ED037416-E0FE-437C-8482-9E2D5083F0D9 Q34255342-B437DA82-0472-4A88-852D-46C71E4782BE Q34629938-6E8F8842-8B61-4079-B5EE-46D7B5739B08 Q35069203-490D1043-C7A8-4D7E-B20E-5100D4AC4DA9 Q35790525-F7356CE0-FCA7-4CCF-8B04-8AC0B69D1869 Q35804988-5F6D5D9F-6F8F-4D0F-B6BF-D766BEE7E387 Q36423189-2B133A1B-4989-42C1-9DA6-F37E3279D534 Q36447934-749FEDDA-5586-4EF5-9888-900FC2F8EB50 Q36810501-64E095A7-3631-45F7-B4EA-2F2D5B8F962E Q37056389-AC56DF01-1996-4500-8F6B-663B74FC91C7 Q37258125-CFA4891E-EF3C-4700-BEAD-9E3BD70E173A Q37553097-20E3BE43-71BA-48F0-B2C1-73D312E2D19F Q37589683-6A4645CE-0C0D-4E58-99D0-2A3D9A2103D2 Q37695914-8D3056D0-3437-4822-91F6-713C89B40621 Q38094888-4F4CB646-3941-4BF1-8ACF-3A1CCDFC278C Q38157013-08A35B95-BF87-484C-9972-844352404BC7 Q38341211-922D953E-EA4E-4968-ACCA-0151084049A7 Q38594874-C6E4D0D3-3527-4C14-BBEE-BEA3C03F7A68 Q38725971-CF7D2DE3-9E81-40C6-845E-BB3BC680910B Q40576443-3381AA77-B58D-43CE-A6FD-E281CB09F283 Q46004871-8D29AE51-FD33-4C03-823F-2219BCF19E97 Q48200863-96DE372A-D57C-4F3F-A2FB-5D31639107DE Q53605401-AC985E86-9EB5-442A-B5C7-7228490E1387

P2860

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

http://www.wikidata.org/entity/Q35917428

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@ast

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@en

type

label

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@ast

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@en

prefLabel

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@ast

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@en

P1433

Q35917428-A1F24C32-B473-4D1A-8772-26964706FD32

P1476

Q35917428-170E0E71-0FEF-4FE8-8CDA-527A6C048196

P2093

Q35917428-32979FB5-0FAB-481C-B608-862DA65E04AC

Q35917428-DB30DB48-3271-4F7C-9712-6D9D2446283B

Q35917428-DC06B58A-7E49-420E-91D2-EC366878571A

Q35917428-E80C6C4C-0A36-433D-A2C2-6C8E82A28E5F

P2860

Q35917428-003A4B09-E8F6-4A14-80F2-75856399BE98

Q35917428-0113F7A4-52C7-4350-BDBD-DC407D8E1FC5

Q35917428-077C27FC-66BA-469D-9F06-C452FB1D817F

Q35917428-10EF85C8-1F38-4630-BE74-7B298D37904B

Q35917428-1439733B-EF08-47AF-B35F-2622397A92B1

Q35917428-1FB0299F-E98C-4BDF-B2EE-200E4FD80440

Q35917428-25A6986E-3415-42DF-9E7E-EEBEB7FCC8D4

Q35917428-2BC3126B-0ECF-4BC1-930A-8EC41B5C4B15

Q35917428-2D4440E0-9BA8-4C4A-92DF-6AF30772D5AF

Q35917428-35FFB96A-0389-4A98-95A6-7F5B443CCC9E

P304

Q35917428-F17BD6A5-D4FC-4D5F-A5FB-CE6DBBA0E4E6

P31

Q35917428-7657A8D1-8217-4C54-B7F2-93FD5D730D46

P356

Q35917428-5C67C37E-D872-4753-84FE-313B0F21DB8B

P433

Q35917428-E7695D2A-A483-4C67-84FC-8BD9DCF9A847

P478

Q35917428-53B5B549-FB0B-4181-902C-AD6E923D09B1

P50

Q35917428-25B06484-FB90-45E7-A9FA-BCB610233568

Q35917428-BF9A82FD-1DD5-4E84-A1A5-2CB8E76703B1

P577

Q35917428-EA4DA5CE-2A81-44FF-BA6A-83FF9FFE6855

P698

Q35917428-AAF0FD99-FF35-4F50-96A2-39D2527B644E

P932

Q35917428-78DA9829-80C5-4397-B7AE-3C41CCA01BB0

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

@en

P2093

Iva Gunnarsson

http://www.w3.org/2001/XMLSchema#string

Sara Olivecrona

http://www.w3.org/2001/XMLSchema#string

Stefan H Jacobson

http://www.w3.org/2001/XMLSchema#string

Tobias E Larsson

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

A new equation to estimate glomerular filtration rate

In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage

PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

P304

727-734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.10331011

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Abdul Rashid Qureshi

Sigrid Lundberg

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22383747

http://www.w3.org/2001/XMLSchema#string

P932

3338280

http://www.w3.org/2001/XMLSchema#string